Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer.Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance,…
Anokion’s $35 Million Equity Funding from Pfizer
